Transurethral plasmakinetic resection of the prostate for benign prostatic hyperplasia

Objective To evaluate the effect and safety of transurethral plasmakinetic resection of the prostate(PKRP) in the treatment of benign prostatic hyperplasia(BPH).Methods Four hundred and eighty-six BPH patients were underwent transurethral plasmakinetic resection of the prostate with Gyrus plasmakinetic system.Results All of the 486 cases were performed successfully.The preoperative estimated weight of the prostate was from 35g to 125g.The mean operation time was 68min(ranged from 42min to 110min).The mean resected tissues weighted 49g.Six cases needed transfusion and there was no transurethral resection syndrome(TRUS) occurred.All patients were followed up for 2 to 13 months postoperatively,the international prostate symptom score(IPSS) decreased from 28.5±3.4 to 10.4±2.9(P0.05),the quality of life(QOL) decreased from 4.8±0.9 to 1.9±0.7(P0.05),and the maximum flow-rate(Qmax) increased from 7.2±2.6 to 19.7±3.2 ml/s(P0.05).Temporary incontinence occurred in 9 cases postoperatively,the secondary hemorrhage in 3,and urethral strictures in 5.Conclusion PKRP is safe and effective for BPH.